![](/images/general/no_picture/200_user.png)
Mychal James Bradley Gibbens
Examiner (ID: 6474)
Most Active Art Unit | 2662 |
Art Unit(s) | 2662 |
Total Applications | 2 |
Issued Applications | 2 |
Pending Applications | 0 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13957909
[patent_doc_number] => 20190055298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => ENGINEERED HIGH-AFFINITY HUMAN T CELL RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 15/990524
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15990524
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/990524 | ENGINEERED HIGH-AFFINITY HUMAN T CELL RECEPTORS | May 24, 2018 | Abandoned |
Array
(
[id] => 16792982
[patent_doc_number] => 20210122799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => SELF-ASSEMBLING PEPTIDE FOR ACTIVATING HUMAN MAST CELLS
[patent_app_type] => utility
[patent_app_number] => 16/617392
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617392
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617392 | Self-assembling peptide for activating human mast cells | May 24, 2018 | Issued |
Array
(
[id] => 15928013
[patent_doc_number] => 20200155640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => LIPO-GLYCOPEPTIDE CLEAVABLE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/615214
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20710
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615214
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615214 | Lipo-glycopeptide cleavable derivatives and uses thereof | May 21, 2018 | Issued |
Array
(
[id] => 15616065
[patent_doc_number] => 20200078437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => Immunoproteasome Inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/613582
[patent_app_country] => US
[patent_app_date] => 2018-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613582
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/613582 | Immunoproteasome inhibitor | May 14, 2018 | Issued |
Array
(
[id] => 15800133
[patent_doc_number] => 20200123209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => ANTIMICROBIAL TYPE-II BACTERIOCINS
[patent_app_type] => utility
[patent_app_number] => 16/612245
[patent_app_country] => US
[patent_app_date] => 2018-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612245
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612245 | Antimicrobial type-II bacteriocins | May 9, 2018 | Issued |
Array
(
[id] => 13444135
[patent_doc_number] => 20180273610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => MODIFIED SERPINS FOR THE TREATMENT OF BLEEDING DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/971692
[patent_app_country] => US
[patent_app_date] => 2018-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15971692
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/971692 | Modified serpins for the treatment of bleeding disorders | May 3, 2018 | Issued |
Array
(
[id] => 14015087
[patent_doc_number] => 20190069537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => Compositions and Methods for Reducing Ice Crystal Formation
[patent_app_type] => utility
[patent_app_number] => 15/969256
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15969256
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/969256 | Compositions and methods for reducing ice crystal formation | May 1, 2018 | Issued |
15/967504 | ABALOPARATIDE FORMULATIONS AND METHODS OF TESTING, STORING, MODIFYING, AND USING SAME | Apr 29, 2018 | Abandoned |
Array
(
[id] => 15831903
[patent_doc_number] => 20200131233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => PROTEINS AND PEPTIDE TAGS WITH ENHANCED RATE OF SPONTANEOUS ISOPEPTIDE BOND FORMATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/606818
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606818
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606818 | Proteins and peptide tags with enhanced rate of spontaneous isopeptide bond formation and uses thereof | Apr 23, 2018 | Issued |
Array
(
[id] => 16381892
[patent_doc_number] => 10806702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Bis-polymer lipid-peptide conjugates and nanoparticles thereof
[patent_app_type] => utility
[patent_app_number] => 15/961111
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 72
[patent_no_of_words] => 20577
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15961111
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/961111 | Bis-polymer lipid-peptide conjugates and nanoparticles thereof | Apr 23, 2018 | Issued |
Array
(
[id] => 15451385
[patent_doc_number] => 20200038516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/500994
[patent_app_country] => US
[patent_app_date] => 2018-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -319
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500994
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500994 | Dosing regimens and related compositions and methods | Apr 8, 2018 | Issued |
Array
(
[id] => 16267343
[patent_doc_number] => 20200268830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => ANTIMICROBIAL COMPOUNDS FROM THE GENUS DELFTIA
[patent_app_type] => utility
[patent_app_number] => 16/496978
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496978
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/496978 | Antimicrobial compounds from the genus | Mar 27, 2018 | Issued |
Array
(
[id] => 15483589
[patent_doc_number] => 10557128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => PSMA binding ligand-linker conjugates and methods for using
[patent_app_type] => utility
[patent_app_number] => 15/934974
[patent_app_country] => US
[patent_app_date] => 2018-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20377
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15934974
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/934974 | PSMA binding ligand-linker conjugates and methods for using | Mar 23, 2018 | Issued |
Array
(
[id] => 17090870
[patent_doc_number] => 11119054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Versatile display scaffolds for proteins
[patent_app_type] => utility
[patent_app_number] => 16/494502
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13068
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494502 | Versatile display scaffolds for proteins | Mar 15, 2018 | Issued |
Array
(
[id] => 16105635
[patent_doc_number] => 10695402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Erythropoietin for gastrointestinal dysfunction
[patent_app_type] => utility
[patent_app_number] => 15/923275
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10895
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923275
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/923275 | Erythropoietin for gastrointestinal dysfunction | Mar 15, 2018 | Issued |
Array
(
[id] => 15438351
[patent_doc_number] => 20200033359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => Immune Profiling Of Tumor Tissue
[patent_app_type] => utility
[patent_app_number] => 16/488449
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488449
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488449 | Immune Profiling Of Tumor Tissue | Mar 1, 2018 | Abandoned |
Array
(
[id] => 15586455
[patent_doc_number] => 20200069762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => COMPOSITIONS OF HYDROLYZED COLLAGEN PEPTIDES AND COMMENSAL MICROORGANISMS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/489890
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489890
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489890 | Collagen hydrolysates as a beneficial prebiotic and their effect on joint inflammation and osteoarthritis | Feb 28, 2018 | Issued |
Array
(
[id] => 15831891
[patent_doc_number] => 20200131227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => POLYPEPTIDE WITH TUMOUR BINDING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/489261
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489261
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489261 | POLYPEPTIDE WITH TUMOUR BINDING ACTIVITY | Feb 26, 2018 | Abandoned |
Array
(
[id] => 15765915
[patent_doc_number] => 20200113975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => Treatment of Lower Urinary Tract Epithelium With Glucagon Like Peptide 2
[patent_app_type] => utility
[patent_app_number] => 16/488628
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488628
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488628 | Treatment of lower urinary tract epithelium with glucagon like peptide 2 | Feb 26, 2018 | Issued |
Array
(
[id] => 13858695
[patent_doc_number] => 10191064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Thyroglobulin quantitation by mass spectroscopy
[patent_app_type] => utility
[patent_app_number] => 15/906078
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 9927
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15906078
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/906078 | Thyroglobulin quantitation by mass spectroscopy | Feb 26, 2018 | Issued |